参考文献

[1]中国体外反搏临床应用专家共识起草专家委员会.中国体外反搏临床应用专家共识.中国心血管病研究，2012，10：81-92.

[2]Labovsky V,Hofer EL,Feldman L,et al.Cardiomyogenic differentiation of human bone marrow mesenchymal cells:role of cardiac extract from neonatal rat cardiomyocytes.Differentiation,2010,79:93-101.

[3]Fernandez PL.A multicenter,prospective,randomized,open-labeled,trial comparing different bonemarrow-derived stem cell approaches in patient with reperfused ST-elevation myocardial infection.European Society of Cardiology Congress 2012(Munich-Germany),25-29.

[4]Bodo-Eckehard Strauer,Gustav Steinhoff.10 Years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart.J Am College Cardiol,2011,58:1095-1104.

[5]Zimpfer D,Aharinejad S,Holfeld J,et al.Direct epicardiac shock wave therapy improve vebtricular function and induces angiogenesis in ischemic heart failure.J Thoracic Cardiovacular Surge,2009,137:963-970.

[6]Yury A,Vasyuk MD,Alia B,et al.Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure.Congest Heart Failure,2010,16:226-230.

[7]Peng Yun-Zhu,Gou Tao,Yang Ping,et al.Effects of extracorporeal cardiac shock wave therapy in patients with ischemic heart failure.Chinese J Cardiol,2012,40:141-146.(https://www.daowen.com)

[8]Song JG,Hwang GS.L.Effects of bilateral stellate ganalion block on autonomic cardiovascular regulation.Circulation,2009,73:1909-1913.

[9]Zan E,Kurt KN,Yousem DM,et al.Spinal cord stimulators:typical positioning and postsurgical complication.Am J Roentgenol,2011,196:437-445.

[10]Rosamond WD,Chambless LE,Heiss G,et al.Twenty-two-year trends in incidence of myocardial infarction,coronary heart disease mortality,and case fatality in 4 US communities,1987-2008.Circulation,2012,125:1848-1857.

[11]Banai S,Ben MS,Parikh KH,et al.Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris:a prospective,opeb-label,multicenter,safety feasibility first-in-man study.J Am Coll Cardiol,2007,49:1783-1789.

[12]Vicol C,Reichart B,Eifert S,et al.First clinical experience with the VSTENT:a device for direct left ventricle-to-coronary artery bypass.Ann Thorac Surg,2005,79:573-579.

[13]Boekstegers P,Raake P,Hinkel R,et al.Hemodynamic and vascular effects of ventricular sourcing by stent-based ventricle to coronary artery bypass in patients with multivessel disease undergoing coronary artery bypass surgery.Circulation,2005,112:1304-1310.